Technology Growth Capital, Inc. (NYSE: HTGC) (“Hercules” or the
“Company”), the leading specialty finance company focused on providing
senior secured loans to venture capital-backed companies in
technology-related markets, including technology, biotechnology, life
science, and energy & renewable technology industries, at all stages of
development, announced today its financial results for the third quarter
ended September 30, 2014.
Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today
disclosed a development program for a P/neurokinin-1 (NK 1 )
receptor antagonist, which is used in the prevention of both acute- and
delayed-onset chemotherapy induced nausea and vomiting (CINV). NK 1
receptor antagonists are administered in combination with a 5-HT 3
receptor antagonist for the prevention of CINV.
Global education leader Houghton Mifflin Harcourt Company (“HMH” or “the
Company”) (NASDAQ: HMHC) today announced its financial results for the
third quarter ended September 30, 2014 as well as an updated outlook for
the full year 2014.
By Priya Anand, MarketWatch
Security researchers have found a new malware that targets Apple (AAPL) users in "the biggest scale we have ever seen" -- a sign that criminals are becoming more proficient at hacking Macs and iPhones.
Revenues Were $1.72 Billion for the Third Quarter of 2014
Segment Operating Margin for the Quarter Was 8.8 Percent
Total Operating Margin Was 10.0 Percent, a 220 bps Improvement Over Q3 2013
Diluted Earnings Per Share Was $1.96 for the Quarter
Cash and Cash Equivalents at the End of the Quarter Were $769 Million
NEWPORT NEWS, Va., Nov.
ICF International, Inc. (NASDAQ:ICFI), a leading provider of consulting
services and technology solutions to government and commercial clients,
reported results for the third quarter ended September 30, 2014.
plc, (NASDAQ: ICLR) a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, today announced that it has been awarded a project by
Food & Drug Administration (FDA) to develop an industry-standard
Patient Reported Outcome (PRO) measure that can be used in
anti-bacterial drug development trials for hospital-acquired bacterial
HABP is the second most common hospital-acquired infection and is the
primary cause of death in intensive care units.
Fiscal 2014 Results (compared to last year) - Total revenue decreased 12% to $2.1 billion - Social gaming revenue increased 28% to $281 million and average bookings per daily active user grew 16% to $0.43
- Adjusted earnings per share decreased 14% to $1.09 - GAAP earnings per share decreased 4% to $0.99 - Returned $319 million to shareholders in the form of share repurchases and dividends Fourth Quarter Results (compared to last year's fourth quarter) - Total revenue decreased 15% to $537 million - Social gaming revenue increased 22% to $75 million and average bookings per daily active user grew 15% to $0.46 - Adjusted earnings per share increased 23% to $0.37 - GAAP earnings per share increased 17% to $0.28 LAS VEGAS , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.